Bernie brings a wealth of corporate experience to Artrya, including 37 years in private and ASX listed companies, spending most of that time in the role of Managing Director.
Bernie was Managing Director of the top ASX listed company Imdex Limited (Imdex) for 20 years, retiring in July 2020. During that time, Imdex’s revenue grew from approximately $20m per annum in Australia to more than of $270m per annum, generated from sales from over 100 countries. In that period, the market capitalization of Imdex grew from below $10m to over $600m, and now exceeds $800m; significantly more than of 60% of revenue was generated from outside Australia.
His vision is for Artrya to become the global standard in non-invasive AI and machine learning to diagnose and treat coronary artery disease. Coronary artery disease is the leading cause of death in the world and Artrya can have a positive impact on lowering this death rate. Artrya’s technology is truly disruptive in an area where technology advances in the past decades have been minimal.
Bernie holds a Bachelor of Business in Accounting, is a qualified Chartered Accountant, and is a fellow of the Australian Institute of Company Directors (FAICD).